(Q44124736)

English

Herpes simplex virus type 1 variants arising after selection with an antiviral carrageenan: lack of correlation between drug susceptibility and syn phenotype

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Herpes simplex virus type 1 variants arising after selection with an antiviral carrageenan: lack of correlation between drug susceptibility and syn phenotype (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Herpes simplex virus type 1

1 reference

based on heuristic

inferred from title

author name string

Carlucci MJ

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Scolaro LA

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Damonte EB

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

92-98

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Antiherpetic activity and mode of action of natural carrageenans of diverse structural types

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Inhibitory action of natural carrageenans on Herpes simplex virus infection of mouse astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Acyclovir-resistant, pathogenic herpesviruses

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Antiviral resistance: mechanisms, clinical significance, and future implications

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Single amino acid substitutions in the glycoprotein B carboxy terminus influence the fusion from without property of herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

In vitro selection of variants of herpes simplex virus type 1 which differ in cytopathic changes

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Thymidine Kinase Deletion Mutants of Herpes Simplex Virus Type 1

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Phenotypic and genotypic characterization of locus Syn 5 in herpes simplex virus 1

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Cyclosporin A resistance of herpes simplex virus-induced "fusion from within" as a phenotypical marker of mutations in the Syn 3 locus of the glycoprotein B gene

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Sulfated polysaccharides extracted from sea algae as potential antiviral drugs

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10174

21 January 2018

Identifiers

10.1002/JMV.10174

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44124736&oldid=2106838746"